The U.S. government committed
$1.95 billion for large-scale manufacturing and delivery of 100 million doses of a COVID-19 vaccine from
Pfizer and BioNTech....The federal government committed up to $955 million to
Moderna for the development of a COVID-19 vaccine...
Johnson & Johnson: The U.S. awarded Johnson & Johnson
$456 million for clinical trials and other vaccine development activities. Under a separate $1 billion
agreement, the U.S. is expected to acquire 100 million doses of J&J’s vaccine, and can buy more doses....
AstraZeneca: The U.S. is providing up to
$1.6 billion for the development, manufacturing, and delivery of AstraZeneca’s vaccine candidate, which is bei...ng developed with the University of Oxford. ...
Novavax: The U.S. awarded
$1.6 billion for late-stage clinical development of Novavax’ vaccine candidate, including a Phase 3 clinical trial, large-scale manufacturing, and the delivery of 100 million doses. ...
Sanofi and GlaxoSmithKline: The U.S. is providing about
$2.1 billion for the development, clinical trials, manufacturing and delivery of 100 million doses of a vaccine from Sanofi and GlaxoSmithKline. ...
Merck and IAVI: The U.S. government awarded Merck and IAVI $38 million for
vaccine research.